ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Keyword Index

Click a keyword to view all the abstracts on this site tagged with that keyword.

  • uric acid and dual energy CT
  • uric acid and genetics
  • uric acid and urate
  • uric acid and utilization review
  • uric acid and vasculogenesis
  • uric acid and vitamins
  • uric acid and weight loss
  • Uric Acid, Urate
  • Urinary Biomarkers
  • Urinary Biomarkers and lupus nephritis
  • Urinary Biomarkers and macrophages
  • Urinary Biomarkers and nephritis
  • Urinary Biomarkers and proteomics
  • Urinary Biomarkers and tumor necrosis factor (TNF)
  • urine
  • Ustekinumab
  • ustekinumab and cytokines
  • Ustekinumab and enthesopathy
  • ustekinumab and infliximab
  • ustekinumab and treatment response
  • utilization review and viscosupplementation
  • UVB
  • Uveitis
  • uveitis and certolizumab pegol
  • uveitis and clinical trials
  • uveitis and turkey
  • uveitis and vasculitis
  • VA
  • Vaccination
  • vaccination and screening
  • vaccine
  • Vaccines
  • vaccines and polymorphism
  • vaccines and viruses
  • Vaginal dryness
  • validation
  • validation and classification criteria
  • Validity
  • Validity and ankylosing spondylitis (AS)
  • Validity and magnetic resonance imaging (MRI)
  • Validity and osteoarthritis
  • Validity and outcome measures
  • Validity and spondylarthritis
  • Validity and spondylarthropathy
  • varicella
  • varicella zoster
  • vascular remodelling and aortic fibrosis
  • vascular ultrasound
  • Vasculitis
  • vasculitis and 18FDG PET/CT scan
  • vasculitis and ANCA
  • vasculitis and antinuclear antibodies (ANA)
  • vasculitis and aortitis
  • vasculitis and Biologics
  • vasculitis and Churg-Strauss syndrome
  • vasculitis and Disease Activity
  • vasculitis and epidemiology
  • vasculitis and Kidney
  • vasculitis and mitochondrial dna
  • vasculitis and quality of life
  • vasculitis and systemic vasculitides
  • vasculitis and Urinary Biomarkers
  • vasculitis and viruses
  • vasculitis and work
  • Vasculitis, Cutaneous
  • vasculogenesis and mucosal T cells
  • vasculopathy
  • vasculopathy and scleroderma
  • VDI and TADS
  • VEDOSS and predictors
  • VEGF
  • venous thromboembolism
  • vertebral deformities
  • Vessel vasculitis
  • Veteran
  • veterans
  • VEXAS syndrome
  • viruses
  • viscosupplementation
  • visual
  • Visual Analog Scale
  • Vitamin C
  • Vitamin D
  • Vitamin D and autoantibodies
  • Vitamin D and bone density
  • Vitamin D and bone turnover markers
  • Vitamin D and cardiovascular disease
  • Vitamin D and family studies
  • Vitamin D and hypercalcemia
  • Vitamin D and hypertension
  • Vitamin D and juvenile idiopathic arthritis-enthesitis (ERA)
  • Vitamin D and menopause
  • Vitamin D and osteoarthritis
  • Vitamin D and osteoporosis
  • Vitamin D and Progressors
  • Vitamin D and rheumatoid arthritis (RA)
  • Vitamin D and rheumatologic disease
  • Vitamin D and systemic lupus erythematosus (SLE)
  • Vitamin D and systemic sclerosis
  • von willebrand factor
  • VTE and Integrated summary of safety
  • wait times
  • walking speed
  • walking speed and thresholds
  • Wearables
  • Web-based Cognitive Behavioral Therapy
  • websites
  • Wegener's
  • Wegener's granulomatosis
  • Wegener's granulomatosis and central nervous system involvement
  • Wegener's granulomatosis and diagnosis
  • Wegener's granulomatosis and infection
  • Wegener's granulomatosis and macrophages
  • Wegener's granulomatosis and meta-analysis
  • Wegener's granulomatosis and microbiome
  • Wegener's granulomatosis and polyangiitis
  • Wegener's granulomatosis and rituximab
  • Wegener's granulomatosis and systemic vasculitides
  • Wegener's granulomatosis and thrombosis
  • Wegener's granulomatosis and vasculitis
  • weight loss
  • Weight training
  • weighted genetic risk score (wGRS)
  • Weighted Genetic Risk Score and Smoking
  • well-being and wellness
  • wellness
  • wellness and qualitative
  • whole genome sequencing
  • whole gut scintigraphy and gastrointestinal tract
  • widespread pain
  • Wikipedia
  • Wild-type transthyretin (TTR) and Lumbar spinal stenosis (LSS)
  • WNT Signaling
  • WNT Signaling and ankylosing spondylitis (AS)
  • WNT Signaling and osteoarthritis
  • WNT Signaling and psoriatic arthritis
  • WNT Signaling and rheumatoid arthritis (RA)
  • wnt5a
  • WOMAC
  • women
  • Women's health
  • WONDER database
  • work
  • work and Social Participation
  • Work Disability
  • Work Disability and adolescent patients
  • Work Disability and ankylosing spondylitis (AS)
  • Work Disability and arthritis management
  • Work Disability and Employment
  • Work Disability and psoriatic arthritis
  • Work Disability and quality of life
  • Work Disability and recruitment
  • Work Disability and rehabilitation
  • Work Disability and rheumatoid arthritis (RA)
  • Work Disability and seronegative spondyloarthropathy
  • Work Disability and systemic lupus erythematosus (SLE)
  • Work Disability and thrombosis
  • Work Disability and vasculitis
  • Work Force
  • Work Participation
  • Workforce
  • Workforce and academics
  • Workforce and access to care
  • Workforce and education
  • Workforce and fellowship programs
  • Workforce and nurse practitioners
  • Workforce and pediatric rheumatology
  • Workforce and rheumatoid arthritis (RA)
  • wounds
  • X chromosome
  • X chromosome and monocytes
  • X-linked and Pediatric lupus
  • X-linked genes
  • X-ray
  • xanthinuria
  • yoga
  • yora
  • young adults
  • young investigators
  • youth
  • zoster
  • zoster and rheumatoid arthritis (RA)
  • First |
  • « Previous Page
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • [66]
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology